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Abstract: Trait anxiety can affect cognitive control resulting in 
ineffective and/or inefficient task performance. Moreover, previous 
functional Magnetic Resonance Imaging (fMRI) studies have reported 
altered dorsolateral prefrontal cortex (DLPFC) activity in anxious 
cohorts, particularly when executive control is required. Recently, it 
has been demonstrated that cortical glutamate levels can predict both 
functional activation during cognitive control, and anxiety levels. In 
the present study we sought to investigate the relationship between trait 
anxiety, prefrontal glutamate levels and functional activation in DLPFC 
during a cognitive control task. Thirty-nine participants assigned to 
either low trait anxiety (LTA) or high trait anxiety (HTA) groups 
underwent 1H-Magnetic Resonance Spectroscopy (1H-MRS) to measure levels 
of resting glutamate in the prefrontal cortex (PFC). Participants also 
completed fMRI during a Stroop task comprising congruent and incongruent 
colour word trials. The HTA group showed reduced task performance 
relative to the LTA group. In the LTA group, there was a positive 
association between PFC Glu levels and DLPFC activation during 
incongruent trials. This association was absent in the HTA group. 
Individual differences in trait anxiety affect the relationship between 
PFC glutamate levels and DLPFC activation, possibly contributing to 
ineffective task performance when cognitive control is required. 
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RE: CORTEX-D-18-00838 
 
Altered relationship between prefrontal glutamate and activation during cognitive control 
in people with high trait anxiety. Morgenroth et al. 
 
13
th
 February 2019 
 
Dear Professor Kirsch, 
 
We thank you for inviting us to resubmit our manuscript. We feel that throughout this 
process the Reviewers’ comments and suggestions have helped to greatly improve the 
manuscript. We have now attempted to address Reviewer 1’s further comments (see 
below). We have particularly focused on Reviewer 1’s request for us to clarify the issues 
around power and null findings. In accordance with this request we have made a further 
amendment to the Discussion section. We hope that this and the other minor changes are 
satisfactory and that we can now publish our manuscript in Cortex. 
 
Yours sincerely  
 
Elenor Morgenroth 
 
 
 
Reviewer #1: 
 I found the manuscript to be very much improved, in particular with regard to the 
theoretical explanation of the research topic and the embedding into the existing 
literature. While I still have reservations regarding the statistical power of the 
study, I recommend this study for publication because of the novelty and relevance 
of the research question. I have some further comments I would like to ask the 
authors to consider. The one point I would suggest as a condition for publication is 
the still more explicit discussion of the power / null finding issue. 
 
You report Bayes Factors for some analyses now. Would you please interpret these 
BFs with reference to some literature about the meaning / significance of these 
Factors? Do I understand correctly, that all the BFs you report are < 1? Then they 
do not really support either the null or the alternative hypotheses? In my opinion, 
you must discuss this in your paper. I would say, everywhere where you mention a 
BF.  
 
We thank the reviewer for this comment and have added more detail regarding the 
interpretation of the Bayes Factors in the Methods section on Page 7   
 
*Detailed Response to Reviewers
 A BF10 > 3 is considered evidence for H1 whereas a BF10 < 1/3 is considered evidence 
for H0 [39]. 
 
And also in the discussion section on the power limitations of your study. I'd say 
your null findings can be interpreted in the sense that there are probably no large 
effects (which you would have had power to detect).  
 
But you do not provide proof - or even strong evidence - that there is actually no 
effect. I find the subject of the study very interesting and recommend it for 
publication. But I strongly suggest that you make this specific limitation even more 
explicit than in the revision so far. Explicitly discuss the meaning of the BF, please. 
And make explicit, that you had sufficient power to detect effects of a size that have 
been reported before. But still, there where pretty large effects (approx. .6 - .9). I'd 
say these are not the smallest effects of interest in research on neural correlates of 
trait anxiety. Explicitly state that there may be smaller effects you did not have 
power to detect with the current sample. 
 
We agree with the reviewer that the power and null effects issue does need further 
discussion and clarification. We have therefore attempted to expand on this issue in the 
Discussion section on Page 17 with a more thorough consideration of the null findings in 
light of the study’s power 
 
First, we report null findings that raise issues regarding the power of the study. Our 
power calculations (Supplementary Material) suggest that the study was sufficiently 
powered to detect medium to large effect sizes (.50 - .90), that have been reported 
previously by studies investigating the associations between DLPFC activity [5], cortical 
glutamate levels [29] and trait anxiety. Clearly however, our study was not sufficiently 
powered to detect smaller effects sizes. This is important because previous studies 
examining the effects of trait anxiety on neurotransmitter levels for example have 
reported smaller effects sizes e.g. [28]). Furthermore, Bayes Factors did not give a 
strong indication for either the null or the experimental hypothesis with regard to the 
relationship between trait anxiety and PFC Glu levels. 
Thus, the null findings reported here need to be interpreted with caution in as much as 
the study sample only provides sufficient power to detect larger effects. We cannot 
discount the possibility that the significant relationships between trait anxiety, DLPFC 
activity and/or cortical glutamate levels might be observed in a study powered to detect 
smaller effects sizes.  
 
I am still wondering, why you did not see a classic Stroop effect in your task as this 
is usually so very robust. Also, mean RTs between 900 und 1100 ms seem to be 
really high for a Stroop task. Could you please discuss that with reference to 
literature on the Stroop task? Could there have been some kind of ceiling effect in 
Stroop RTs that prevent you from seeing the classic differences between 
incongruent (IC) and congruent (CO) trials. And if so, any ideas why? Is there 
something in your version of the task that makes IC and CO more similar than 
usually?  
 
We used a single-handed 4-finger button box rather than a 2-hand, 2-finger response 
system, as used in previous studies (e.g. Basten et al. 2011). We cannot be sure how this 
affected our behavioural results during the Stroop task but it is possible that this response 
set-up may have led to relatively high reaction times compared to other studies. Reaction 
times were distributed symmetrically and the high mean and lack of Stroop effect does 
not seem to be driven by outliers. We addressed this in the Discussion on Page 15. 
 
It is unclear why this reaction time pattern was observed but it may have been due to a 
speed accuracy trade-off, trial/task pacing [54], or because the version of the task used 
in the present study used a single handed four-finger response system accounting for the 
relatively high reaction times observed in both congruent and incongruent task 
conditions. . 
 
I would still expect more and stronger differences in BOLD for the two conditions 
even at .05 FWE, and some effect in the default mode network - after all, you are 
studying 39 subjects here.  
 
Throughout our manuscript we have reported effects at a strict peak-level corrected 
threshold (p <.05 FWE). At a cluster corrected level (p =.05 FWE) there is more 
extensive activation in the anterior cingulate extending to the supplementary motor area 
and also the bilateral DLPFC and superior parietal lobes, caudate/putamen and 
cerebellum. Taking into account the strict threshold our results do compare to previous 
research using the Stroop task in fMRI (e.g. Zysett et al. 2007). 
  
For the association between anxiety and BOLD anti in DLPFC you write: "The 
effect of trait anxiety (STAI trait scores) on DLPFC activation was non-significant 
in bilateral DLPFC ROI during Incongruent > Congruent trials." Could you 
quantify what non-significant means here? As you are working with a priori defined 
ROIs, you could extract beta estimates from these ROIs and calculate the 
corrections offline. Also the association between anxiety and GLU could be 
calculated as a correlation offline to provide an estimate of the effect size of 
association when considering both as continuous variables. This would be useful 
information for the reader. 
 
We have added the requested correlation between Trait Anxiety and PFC Glu Corr levels 
to the Results section. 
 
Page 13 
The correlation between Trait anxiety scores and PFC Glu Corr levels was also non-
significant (r = .25 p = .121).  
 
As requested, we have also calculated the correlation between beta estimates and trait 
anxiety scores offline, which was r = -.04, p = .809 for the right DLPFC ROI and r = .03, 
p = .880 for the left DLPFC ROI. We did not include these in the manuscript as we 
explicitly do not want to present any secondary and potentially non-independent testing 
with extracted beta values from fMRI analyses (Vul et al. 2009; Eklund et al. 2016). 
 
I found the theoretical explanations to be very much improved in general. One point 
that is still not clear to me is why "... the absence of this relationship between resting 
Glu levels and DLPFC activity in the HTA group may result in ineffective task 
performance". How is the association of GLU and BOLD important or necessary 
for successful task performance - or how could it be theoretically. 
 
We have previously tried to address this issue in the Introduction and Discussion of the 
revised manuscript. Essentially, the precise relationship between resting PFC Glu levels 
and neural activity during cognitive control are not fully understood. However, we have 
tried to develop our theoretical argument by making suggestions for future work using 
task related MRS that could provide greater insight into underlying processes. We have 
expanded upon this in the Discussion on Page 18. 
 
Page 18 
Thus, future work could measure task-related differences in Glu levels to obtain a more 
accurate and dynamic insight into the neural basis of cognitive processes [67]; combined 
fMRI and MRS i.e. scan data collected simultaneously is a promising method to better 
understand the relationship between BOLD and neurotransmitter levels in the context of 
task processing [68]. 
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ABSTRACT 
Trait anxiety can affect cognitive control resulting in ineffective and/or inefficient task 
performance. Moreover, previous functional Magnetic Resonance Imaging (fMRI) studies 
have reported altered dorsolateral prefrontal cortex (DLPFC) activity in anxious cohorts, 
particularly when executive control is required. Recently, it has been demonstrated that 
cortical glutamate levels can predict both functional activation during cognitive control, and 
anxiety levels. In the present study we sought to investigate the relationship between trait 
anxiety, prefrontal glutamate levels and functional activation in DLPFC during a cognitive 
control task. Thirty-nine participants assigned to either low trait anxiety (LTA) or high trait 
anxiety (HTA) groups underwent 
1
H-Magnetic Resonance Spectroscopy (
1
H-MRS) to 
measure levels of resting glutamate in the prefrontal cortex (PFC). Participants also 
completed fMRI during a Stroop task comprising congruent and incongruent colour word 
trials. The HTA group showed reduced task performance relative to the LTA group. In the 
LTA group, there was a positive association between PFC Glu levels and DLPFC activation 
during incongruent trials. This association was absent in the HTA group. Individual 
differences in trait anxiety affect the relationship between PFC glutamate levels and DLPFC 
activation, possibly contributing to ineffective task performance when cognitive control is 
required. 
*Manuscript - with changes highlighted
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 2 
1. INTRODUCTION 
Trait anxiety is a normally distributed personality dimension and a risk factor for anxiety and 
depressive disorders [1, 2] characterised by intrusive thoughts, worry and difficulty in 
disengaging from negative material [3]. Trait anxiety has been found to be associated with 
functional consequences including increased distractibility and attention problems [4-6]. 
Indeed, the effects of trait anxiety on cognitive function have long been recognised [7] and 
are accounted for by attentional control theory (ACT; [6, 8]).  
ACT proposes that anxiety competes for attentional resources and impairs cognitive control 
when executive processes are required i.e., updating, set shifting and inhibiting irrelevant or 
distracting information. Consequently, anxiety can impair task performance i.e. performance 
effectiveness when executive control is required. Further, ACT predicts that, even when 
performance effectiveness is maintained, anxiety can reduce processing efficiency (the 
quality of performance relative to use of processing or cognitive resources). In line with this 
prediction, functional Magnetic Resonance Imaging (fMRI) studies report increased 
prefrontal cortex (PFC) activation in people with high trait anxiety without concomitant 
improvements in performance effectiveness (i.e. processing inefficiency; [9-11]). The PFC 
along with the lateral parietal cortices i.e. the fronto-parietal network (FPN), are known to be 
important for cognitive control [12, 13] and support ‘top-down’ attention by maintaining 
attentional sets [12, 14, 15]. In particular the dorsolateral prefrontal cortex (DLPFC), 
comprising the middle and superior frontal gyri, has a central role in top-down cognitive 
control [16] and has been shown to have altered activation in response to tasks that require 
cognitive control in people with high trait anxiety (e.g. [5, 9-11]). 
Despite these recent advances in our understanding of the neural mechanism involved in 
cognitive control, little is known about its neurochemistry and how this may be affected by 
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 3 
individual differences in trait anxiety. Glutamate (Glu) is an excitatory neurotransmitter and 
its importance in cognitive control has been highlighted in animal models [17, 18]. In 
humans, Anticevic and colleagues [19] showed that administration of ketamine, an N-methyl-
D-aspartate glutamate receptor (NMDAR) antagonist, disrupts activity in FPN regions and 
subsequent performance during a working memory task, highlighting the role that Glu plays 
in cognitive control. Combining functional Magnetic Resonance Imaging (fMRI) and 
1
H-
Magnetic Resonance Spectroscopy (
1
H-MRS), Falkenberg and colleagues [20] demonstrated 
that the magnitude of the blood-oxygen level-dependent (BOLD) response to a task requiring 
cognitive control was predicted by anterior cingulate resting state Glu levels. Moreover, 
individual variability in resting Glu levels was related to how the brain implements cognitive 
control [20].  
These findings are important because Glu functioning is altered in some psychiatric disorders 
associated with cognitive control impairments [21] and pharmacologically induced reductions 
in Glu levels have been found to alter the BOLD response during cognitive control tasks [22, 
23]. However, whilst in vivo 
1
H-MRS studies investigating the neurobiology of anxiety have 
focused on populations with diagnosed disorders (e.g. [24-27]), 
1
H-MRS studies in non-
clinical populations in which trait anxiety is assessed as a personality dimension are relatively 
few in number. The first study using 
1
H-MRS to examine metabolite levels in relation to trait 
anxiety reported increased PFC N-Acetyl aspartate (NAA) in participants with high trait 
anxiety levels but found no differences in Glu levels between high and low trait anxiety 
participants [28]. More recently, Modi and colleagues [29] reported that cortical Glu and 
combined Glu and glutamine levels (measured with 
1
H-MRS in the anterior cingulate) were 
increased in participants with high relative to low trait anxiety scores and predictive of trait 
anxiety levels across their study cohort. Pharmacologically induced anxiety has also been 
reported to increase cortical Glu levels [30].  
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 4 
Together, the studies discussed here indicate that trait anxiety can affect both DLPFC activity 
during cognitive control and PFC Glu levels. Whilst it has already been established that 
resting cortical Glu levels are important for the way the brain implements cognitive control 
[19, 20], to date, no studies have measured resting cortical Glu levels and DLPFC activity 
during a cognitive control task and examined how these are related to individual differences 
in trait anxiety levels. This is important because it is possible that the effects of trait anxiety 
on DLPFC activity (and cognitive control) are influenced by cortical Glu levels. Although the 
precise relationship between resting PFC Glu levels and neural activity is not fully 
understood, a number of studies have shown that levels of resting Glu measured with 
1
H-
MRS are related to the BOLD signal and electrophysiology measures during cognitive tasks 
[20, 31-33] and possibly mediated via NMDAR [19]. 
The aim of the present study was to investigate the relationship between trait anxiety, PFC 
Glu levels (using 
1
H-MRS) and activity in DLPFC during a cognitive control task. In 
accordance with the predictions of ACT and findings from previous fMRI studies, we 
hypothesised that levels of trait anxiety would be positively associated with DLPFC activity 
during a cognitive control task (indicative of processing inefficiency). Based on the findings 
outlined above, we then tested if participants with high levels of trait anxiety had elevated 
levels of PFC Glu relative to a low trait anxiety group. Finally, we explored how the 
association between resting PFC Glu levels and DLPFC activity during cognitive control was 
affected by individual differences in trait anxiety levels. No part of the study procedures or 
analyses was pre-registered in a time-stamped, institutional registry prior to the research 
being conducted. 
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2. METHODS 
We report how we determined our sample size (see Supplementary Materials). No data were 
excluded and inclusion/exclusion criteria are reported below. Inclusion/exclusion criteria 
were established prior to data analysis as were all manipulations, and all measures in the 
study. The raw data and materials to replicate this study or any analysis are available at Open 
Science Framework (DOI 10.17605/OSF.IO/PXK8Z). 
2.1.Participants and assessments 
Thirty-nine participants performed a colour-word Stroop task [34] while functional magnetic 
resonance imaging and 
1
H-MRS data were acquired. Participants (27 female) ranged from 18-
37 years of age (M = 22.05 years, SD = 4.62). There were 35 right handed and four left 
handed participants, as assessed by the Annett Hand Preference Questionnaire [35]. 
Participants were recruited from the University of Roehampton, Royal Holloway University 
of London and from the general public. Participants had no prior neurological or medical 
illness and were not using medication for anxiety or depression. The University of 
Roehampton Ethics Committee gave ethical approval and all participants gave written 
informed consent prior to taking part in the study. IQ was estimated using the Wide Range 
Achievement Test (WRAT-R) Reading Level 2 [36]; M = 109.15 (SD = 10.24, Range 86-
131) to control for potential effects of IQ on task performance and task-related BOLD signal. 
Alcohol consumption and recreational cannabis use were assessed for all participants using a 
categorical scale (ranging from no-use to regular use). The majority of participants indicated 
that they used alcohol on a moderate basis and that they used cannabis never or only 
experimentally (see Table s1).  
To assess trait anxiety, participants completed the State Trait Anxiety Inventory (STAI) [37]. 
In all participants the mean score for trait anxiety was 41.33 (SD = 11.07, Range 22-78) and 
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 6 
33.2 (SD=10.01, Range = 20-70) for state anxiety. This distribution of STAI trait scores is 
slightly higher than published norms (i.e. M = 36, SD = 10) [37] but comparable to scores 
reported by a previous study examining effects of trait anxiety on DLPFC activation (i.e. M = 
43 SD = 11) [5].  
A median-split of STAI trait scores was used to establish low trait anxious (LTA; n = 19) and 
high trait anxious (HTA; n = 20) groups (see results), this dichotomization was performed to 
achieve greater interpretability of the results. Confirmatory analysis of behavioural and MRI 
data using STAI trait scores as a continuous variable are reported in the Supplementary 
Materials. 
2.2.Experimental Task 
Participants performed a colour-word Stroop task adapted for MRI and used previously [38]. 
The task was programmed and presented with Microsoft Visual Basic. Participants responded 
with one of four fingers of their right hand to the font colour of the word presented (Red, 
Yellow, Blue or Green). Participants were instructed to respond as quickly and as accurately 
as possible while reaction times (RT) and error rates (ER) were recorded. The task consisted 
of a total of 100 trials, 33 congruent trials in which the font colour and meaning of the word 
matched, 33 incongruent trials in which the font colour and meaning of the word did not 
match and 34 fixation periods in which the participants saw a fixation cross. Trials were 
presented in a pseudo-randomized order within one functional run lasting 10 minutes. Each 
trial (including fixation cross trials) was presented in the middle of the screen and took 6000 
ms including a period of 1300 ms before trial onset in which a blank dark grey screen was 
displayed. Participants then viewed a visual stimuli (i.e. congruent word, incongruent word, 
or fixation cross) that was presented for 700 ms. Thus participants were allowed 4700 ms 
from stimulus onset (700 ms during trial presentation plus 4000 ms response period) to 
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 7 
respond i.e. responses were registered from the onset of each stimulus trial. After a response 
was registered the trial continued until the end of this period. No response was required in 
fixation cross trials. 
2.3.Statistical Analysis and Power 
IBM® SPSS Statistics Version 22 was used for the analysis of task and questionnaire data. 
Questionnaire and task data were considered normally distributed. A multifactorial repeated 
measures ANOVA with the dependent variables RT and ER in the two conditions of the 
Stroop task (Congruent, Incongruent) was performed. Trait anxiety group was included as a 
between subjects factor. A statistical significance threshold of p < .05 was applied 
throughout. To test if analyses were sufficiently powered we used G*Power 
(https://download.cnet.com/G-Power/3000-2054_4-10647044.html). Power calculations are 
reported in Supplementary Material. Furthermore, we used statistical software program JASP 
(JASP Team, 2016; jasp-stats.org) to compute Bayes Factor (BF10) to quantify the relative 
likelihood of the model tested to the null hypothesis. A BF10 > 3 is considered evidence for 
H1 where as a BF10 < 1/3 is considered evidence for H0 [39]. LTA and HTA groups were 
compared on STAI trait and state scores, IQ estimate and age using independent samples t-
tests. The groups were also compared on their alcohol consumption and cannabis use using 
Mann-Whitney U tests for ordinal data. 
2.4.MRI Acquisition 
All MRI scans were acquired on a 3T Siemens Magnetom TIM Trio scanner using a 32-
channel head coil. Structural T1 weighted Magnetization Prepared Rapid Acquisition 
Gradient Echo (MP RAGE) images were acquired with a spatial resolution of 1 mm × 1 mm 
× 1 mm, in plane resolution of 256 × 256 × 176 slices and scanning time of approximately 5 
minutes. Functional images were acquired using a full-brain, anterior-to-posterior, T2* 
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 8 
weighted, BOLD-sensitive gradient echo planar sequence with the following parameters: 
TR/TE/flip angle = 2 s/40 ms/70°, field of view 192 mm × 192 mm and slice thickness of 5 
mm giving a voxel size of 3 mm × 3 mm × 5 mm and whole brain coverage of 28 interleaved 
slices. Three hundred volumes were collected during the event related functional run.  
2.5.
1
H-MRS data acquisition and analysis 
1
H-MRS in vivo spectra were acquired from a 20 × 20 × 20 mm voxel located in the right 
medial PFC during rest. A voxel in the right PFC was chosen as previous fMRI studies report 
effects of anxiety in the right PFC [9, 10]. A medial position was chosen as lateral voxels can 
be harder to place due to tissue boundaries. The voxel was positioned manually by reference 
to an axial T1- weighted gradient echo image (Figure 3B). Spectra were acquired using SPin 
ECho full Intensity-Acquired Localized spectroscopy (SPECIAL; [40]) 
1
H-MRS sequence 
with water suppression (TR 3000 ms, TE 8.5 ms, Phase cycle Auto, 192 averages from the 
right PFC voxel) in each participant [41]. Water unsuppressed spectra (16 averages) were 
also acquired. Six outer volume suppression slabs were applied (one on each side at 5mm 
from the edge of the cubic voxel) to suppress signals originating from outside the volume of 
interest and to minimize motion-related image-selected in vivo spectroscopy subtraction 
artifacts. Spectra were analysed using LCModel 6.3-1L with the basis set consisting of 19 
simulated basis spectra; alanine (Ala), ascorbate (Asc), aspartate (Asp), creatine (Cr), γ-
aminobutyric acid (GABA), glucose (Glc), glutamine (Gln), glutamate (Glu), glycine (Gly), 
glutathione (GSH), glycerophosphocholine (GPC) phosphocholine (PCh), lactate (Lac), myo-
inositol (mI), N-acetylaspartate (NAA), N-acetylaspartateglutamate (NAAG), 
phosphorylethanolamine (PE), scyllo-inositol (Scyllo) & taurine (Tau). 
The basis set was simulated using FID-A [42], for TE = 8.5 ms, magnetic field strength = 3 T 
and assuming ideal RF pulses. We excluded spectra with Cramer-Rao lower bounds (CRLB) 
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> 20% as reported by LCModel. In addition to metabolite levels, line widths and signal-to-
noise ratios were estimated by LCModel. All spectra had a Line Width < 8 Hz and an SNR > 
40 [41]. 
Metabolite levels have been shown to depend on the amount of cerebral spinal fluid (CSF), 
gray (GMV) and white matter (WMV) within the voxel [43], and inter-individual differences 
in cortical gray matter [44]. Correlations between PFC Glutamate and GMV and WMV 
WMV are reported in the supplementary material. To account for these potential confounds 
we used the T1-weighted anatomical images to estimate the gray and white matter content of 
the right PFC voxel in which the 
1
H-MRS measures were performed using GABA Analysis 
Toolkit (Gannet 2.0, http://gabamrs.blogspot.co.uk/) adapted to work with Siemens SPECIAL 
data. The segmentation was performed using “new segment” in SPM 8 
(http://www.fil.ion.ucl.ac.uk/spm/software/spm8/). CSF, GMV and WMV were then 
accounted for in the expression of Glu and GABA levels using LCModel [45, 46]; corrected 
metabolite levels are referred to as Glu Corr and GABA Corr using the formula Glu Corr = 
(Glu*(43300*GMV+ 35880*WMV+55556*CSF))/(35880*(1-CSF)) and GABA Corr = 
(GABA*(43300*GMV+ 35880*WMV+55556*CSF))/(35880*(1-CSF)). 
Additionally, because previous studies investigating the relationship between Glu and BOLD 
signal during cognitive control have used metabolite ratios relative to the synchronously-
acquired Cr signal [20, 47] we report Glu/Cr results in a supplementary analysis 
(Supplementary Materials). Differences between LTA and HTA groups in right mPFC 
metabolite levels, as well as SNR, Line Width and CRLB were established using independent 
sample t-tests. Additionally, we calculated the BF10 for each comparison to assess the 
likelihood of the model relative to the null hypothesis. As no a-priori hypotheses for other 
1H-MRS metabolite levels were stated, statistical tests for GABA, NAA, Myo-inositol, 
Choline and Creatine by trait anxiety group are reported in Supplementary Material.  
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2.6.fMRI data analysis 
Functional MRI data were analysed using the Statistical Parametric Mapping software 
package (SPM12, Welcome Department of Cognitive Neurology, London, UK, 
www.fil.ion.ucls.ac.uk/spm/spm12). The anatomical and Echo Planer images (EPI) were 
reoriented manually based on the anterior commissure - posterior commissure axis. The 
images were corrected for slice timing. Motion correction was performed for functional 
images using six movement parameters to reduce motion artefacts. Volumes were co-
registered to the high-resolution T1-weighted image and normalized into the Montreal 
Neurological Institute (MNI) template using parameters generated by unified segmentation of 
the T1-weighted structural image. The transformed data were smoothed using an 8 mm full 
width at half maximum (FWHM) isotropic Gaussian kernel. A high-pass filter with a cut-off 
of 128 s was applied to reduce low-frequency noise. 
A fixed effects general linear model (GLM) was used to model data from the Stroop task at 
the 1
st
 level based on event related Congruent and Incongruent colour-word trials. The 
number of error trials were modelled as regressors of no interest and Fixation cross trials 
were modelled implicitly. The six motion correction parameters were included as regressors 
of no interest in 1
st
 level models. Contrast images were created for each participant at the 1st 
level to examine the main effect of condition (Congruent vs. Incongruent). The contrast 
Incongruent > Congruent was specified for each 1
st
 level model to establish the effect of 
interference on whole brain activity at the single subject level.  
These 1
st
 level contrasts were then entered into a second-level ANCOVA to examine the 
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main effect of task (Incongruent > Congruent trials). To assess the effect of trait anxiety on 
DLPFC activation we entered 1
st
 level contrast images into a regression model in SPM v12 as 
power was insufficient to detect small to medium effects using an independent samples t-test 
(See Supplementary Material).  
These 1
st
 level contrasts were entered into a second-level ANCOVA with each participants 
trait anxiety group (LTA vs. HTA) and PFC Glu Corr levels to examine task related 
activation during incongruent trials (Incongruent > Congruent), the effect of trait anxiety 
group on task related activation and the interaction effect for group x Glu Corr levels. 
Furthermore each participant’s mean ER were included as a covariate of no interest to control 
for the effects of task performance on brain activation as these different between LTA and 
HTA groups. As the effect of group on estimated IQ scores was non-significant we chose not 
to include estimated IQ as a covariate in ANCOVA.  
 Because of our a-priori hypothesis that trait anxiety would specifically be associated with 
increased activity in DLPFC regions during a task requiring cognitive control we used a 
region of interest (ROI) approach (x, y, z = +/-34, 36, 24, small volume correction (SMV) 
sphere = 12mm). The DLPFC ROI was based on previous reviews of fMRI tasks that 
manipulate cognitive control [48, 49] and a previous study which reports a positive 
correlation between trait anxiety and DLPFC activity during a high load condition [5]. As 
effects of anxiety have been reported in left [5], right [9, 10, 50] and bilateral DLPFC activity 
[11, 51] we chose to test for effects in a bilateral DLPFC ROI. Exploratory full brain analyses 
are reported in Supplementary Materials. For all analyses ER were included as a covariate of 
no interest. Significance results are reported at a threshold of p<.05 (FWE-peak-level). To 
represent results graphically parameter estimates of activation were extracted from the peak 
voxel in analyses. No secondary analyses were performed on the extracted values [52, 53]. 
Plotting served the purpose of disentangling the effect revealed in the GLM. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 12 
3. RESULTS 
3.1.Trait anxiety groups 
A median-split based on STAI trait scores (median = 42) was used to establish low trait 
anxious (LTA) and high trait anxious groups. LTA and HTA groups differed significantly on 
STAI trait and state anxiety scores but not in age, or estimated IQ scores. There were no 
significant group differences between groups in alcohol consumption or cannabis use (See 
Table 1).  
TABLE 1 HERE 
3.2.Task Performance 
Error rates: Participants’ ER and RT during the Stroop task are shown in Figure 1. ANOVA 
revealed a significant effect of condition for ER (F(1, 37) = 24.89, p < .001, ηpart² = .40) with 
a greater ER during incongruent trials across all participants. There was also a significant 
effect of trait anxiety group on ER (F(1, 37) = 4.63, p = .038, ηpart² = .11) and significant 
group x task condition interaction effect (F(1, 37) = 7.59, p = .009, ηpart² = .17) revealing that 
ER were greater in the incongruent condition for the HTA group.  
Reaction Times: The main effect of condition on RT was non-significant (F(1,37) = 1.84, p = 
.183, ηpart² = .05), however there was a significant effect of trait anxiety group on RT (F(1, 
37) = 4.54, p = .040, ηpart² = .11). Across the task the HTA group were slower than the LTA 
group. The group x task condition interaction was non- significant (F(1, 37) = 0.13, p = .717, 
ηpart² < .01). The relative likelihood of this model compared to the null hypothesis is BF10 = 
0.29. 
FIGURE 1 HERE 
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3.3.fMRI: Stroop Effect 
Compared to Congruent trials, Incongruent trials were associated with activation in the 
bilateral medial superior frontal gyrus and anterior cingulate cortex, the bilateral precentral 
gyrus extending to the right middle frontal, and in the left middle frontal and inferior gyrus 
and putamen (see Figure 2 and Table s2). There was no significant activation in the opposite 
contrast (Congruent > Incongruent trials) at a FWE corrected level of p <.05.  
FIGURE 2 HERE 
 
3.4.Effect of trait anxiety on DLPFC activity during incongruent trials 
The effect of trait anxiety (STAI trait scores) on DLPFC activation was non-significant in 
bilateral DLPFC ROI during Incongruent > Congruent trials.  
3.5.
1
H- MRS: Glu Corr and DLPFC activation 
PFC Glu Corr metabolite levels and spectra quality control data for LTA and HTA groups are 
reported in Table 2. All other metabolite levels are reported in Table s3. Differences between 
LTA and HTA groups for right PFC Glu Corr were non-significant (relative likelihood of this 
model compared to the null hypothesis BF10 = 0.64). The correlation between Trait anxiety 
scores and PFC Glu Corr levels was also non-significant (r = .25 p = .121). 
TABLE 2 HERE 
There was a significant interaction between PFC Glu Corr levels and trait anxiety group in 
the left DLPFC ROI (x, y, z = -26, 30, 18, Z = 3.60; PFWE (Peak-level) = .044) (Figure 3C). The 
scatter plot in Figure 3A shows that during incongruent trials (Incongruent > Congruent) the 
LTA group showed a positive association between PFC Glu Corr levels and brain activity in 
the left middle frontal gyrus.  
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In the HTA group, during incongruent trials, PFC Glu Corr levels were not associated with 
activation in the DLPFC ROI. This interaction effect was not accounted for by task 
performance (ER).  
FIGURE 3 HERE 
 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 15 
4. DISCUSSION 
The aim of this study was to examine the relationship between trait anxiety, DLPFC 
activation during a cognitive control task, and PFC Glu levels. Overall, participants 
performed the Stroop task with a high level of accuracy. As expected, during the Stroop task, 
error rates were greater during incongruent trials although unusually, reaction times did not 
differ significantly between congruent and incongruent conditions. It is unclear why this 
reaction time pattern was observed but it may have been due to a speed accuracy trade-off, 
trial/task pacing [54], or because the version of the task used in the present study used a 
single handed four-finger response system accounting for the relatively high reaction times 
observed in both congruent and incongruent task conditions. However, relative to the LTA 
group, the HTA group had greater ER during incongruent trials and were generally slower 
across the task. Reduced task performance (i.e. increased ER and RT) in the HTA group is 
consistent with the prediction that high levels of trait anxiety reduce performance 
effectiveness [6]. Reduced performance effectiveness during the incongruent trial condition of 
the Stroop task has been reported previously in anxious individuals [9, 55] and may be related 
to the high cognitive control requirements of the task.  
During the Stroop task, fMRI data showed that incongruent (> congruent) trials were 
associated with activity in the anterior cingulate cortex (ACC) and medial superior frontal 
gyrus (supplementary motor area), the bilateral precentral gyrus, right middle frontal gyrus 
and left middle and inferior frontal gyri (as well as smaller activations in a number of 
subcortical regions). This finding is broadly consistent with previous fMRI studies/meta-
analyses reporting functional activation during the Stroop task (e.g. [9, 56-58]). It is assumed 
that incongruent trials increase activity in ACC, supplementary motor area, and DLPFC 
regions due to the increased need for cognitive control.  
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In people with high trait anxiety, increased DLPFC activation without improved task 
performance effectiveness has been interpreted as reduced processing efficiency [9-11]. 
However, contrary to some previous fMRI findings, trait anxiety was not significantly 
associated with increased activation in the DLPFC during incongruent trials. Nevertheless, in 
the present study, the HTA group did demonstrate reduced performance effectiveness relative 
to the LTA group, suggesting that their DLPFC activation during incongruent trials may have 
been insufficient to perform the task effectively.  
It has been reported previously that cortical Glu levels can predict anxiety levels [29] and that 
pharmacologically induced anxiety increases cortical Glu levels [30]. Examining our 
1
H-
MRS data however, there were no significant differences in PFC Glu levels between LTA 
and HTA groups. This may be due to our 
1
H-MRS voxel placement, in the medial PFC, 
which differed from the ACC voxel placement used in these previous studies [20, 21]. We 
then examined how trait anxiety influenced the relationship between PFC Glu levels and 
DLPFC activation during cognitive control. We found a significant interaction between PFC 
Glu levels, trait anxiety and left DLPFC activation during incongruent task trials. This effect 
was driven by a positive association between PFC Glu levels and DLPFC activation in the 
LTA group, while PFC Glu and DLPFC activation were unrelated in HTA participants. This 
finding suggests a role for resting PFC Glu in DLPFC activation and is in line with previous 
studies by Falkenberg and colleagues [20] and Duncan and colleagues [47] that report resting 
Glu levels significantly influence how the brain implements cognitive control. Although 
speculative, resting PFC Glu may facilitate efficient processing during cognitive control 
through a higher capacity for energy turnover [59] and/or NMDAR function [19] that 
increase DLPFC activity in line with task demands. It should be made clear however, that the 
relationship between resting Glu concentrations and neural energy metabolism in humans is 
not fully understood [60, 61]. Thus, in the LTA group it is possible that such a positive 
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relationship between excitatory neurotransmission and task related activation in the DLPFC 
facilitates an effective and/or efficient neural processing mechanism when cognitive control 
is required. On the other hand, in the HTA group, no association between resting Glu levels 
and DLPFC activity was observed. This could be due to effects of trait anxiety on NMDAR 
function. Anxiety and neuroticism (a personality construct closely linked to trait anxiety) 
have been shown to affect NMDAR function [62, 63] and differences in NMDAR function 
can effect task-related interactions between default mode and FPN regions [19, 64]. The 
absence of this relationship between resting Glu levels and DLPFC activity in the HTA group 
may result in ineffective task performance; consistent with the predictions of ACT [6]. 
Together, these findings provide new insight into how a normally distributed personality 
dimension such as trait anxiety can affect the relationship between excitatory 
neurotransmission and activation in neural regions that support cognitive control. Future 
work could investigate if modulation of excitatory neurotransmission can ameliorate anxiety 
related effects on cognition. 
4.1.Limitations  
First, we report a number of null findings which raise issues regarding the power of the study. 
Our power calculations (Supplementary Material) suggest that the study was sufficiently 
powered to detect medium to large effect sizes (.50 - .90), that have been reported previously 
by studies investigating the associations between DLPFC activity [5], cortical glutamate 
levels [29] and trait anxiety. Clearly however, our study was not sufficiently powered to 
detect smaller effects sizes. This is important because previous studies examining the effects 
of trait anxiety on neurotransmitter levels for example have reported smaller effects sizes 
(e.g. [28]). Furthermore, Bayes Factors did not give a strong indication for either the null or 
the experimental hypothesis with regard to the relationship between trait anxiety and PFC 
Glu levels. 
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Thus, the null findings reported here need to be interpreted with some caution in as much as 
the study sample only provides sufficient power to detect larger effects. We cannot discount 
the possibility that the significant relationships between trait anxiety, DLPFC activity and/or 
cortical glutamate levels might be observed in a study powered to detect smaller effects sizes. 
Thus future studies aiming to examine the effect of trait anxiety on PFC Glu would need to 
recruit larger samples. It should also be noted that four of the 39 study participants were left-
handed and laterality may affect stoop task performance [65]. 
Second, 
1
H-MRS-fMRI analyses did not show any interaction effects within the right medial 
PFC voxel itself. Similar findings have been reported previously [20, 47], where no 
relationship between Glu and BOLD signal was seen in the measured region. This points to a 
more global effect of Glu on BOLD response, exerting ‘long-range’ influence on other 
regions via glutamatergic projection [20]. Notably this study relies on resting state Glu 
measurements rather than examining changes in these metabolite levels as a result of task 
demands. Though the use of resting-state MRS is common practice, PFC Glu levels differ 
between rest and task and reflect changes in other metabolic measures and cognitive demands 
[66]. Thus, future work could measure task-related differences in Glu levels to obtain a more 
accurate and dynamic insight into the neural basis of cognitive processes [67]; combined 
fMRI and MRS i.e. scan data collected simultaneously is a promising method to better 
understand the relationship between BOLD and neurotransmitter levels in the context of task 
processing [68]. 
Third, the concept of processing efficiency/inefficiency that is central to ACT does not tell us 
about the precise neural mechanisms that underlie the different patterns of brain activation in 
people with high levels of anxiety. For example, differences in intensity and timing of neural 
signalling (i.e. temporal dynamics) as well as resting cerebral blood flow and metabolism 
would be likely to affect activation in fMRI experiments [69]. However, we have shown here 
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that excitatory neurotransmission can modulate task related activation in the PFC and that 
this modulation effect is perturbed in people with high trait anxiety. Finally, there is emerging 
evidence that cognitive deficits in people with high trait anxiety/anxiety disorders are partly 
due to functional network imbalances (see [13]). Future work should examine how network 
interactions (i.e. FPN and Default Mode Network) are modulated by excitatory/inhibitory 
neurotransmission and how these interactions are affected by anxiety.  
4.2.Conclusions  
We have demonstrated that individual differences in trait anxiety affect the relationship 
between PFC Glu levels and DLPFC activation during cognitive control. This may contribute 
to ineffective task processing when cognitive control is required. These results need to be 
replicated in larger samples and more work is needed to examine how task related excitatory 
neurotransmission during cognitive control is affected by trait anxiety.  
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TABLES AND FIGURES 
Table 1. STAI scores, age, estimated IQ, alcohol and cannabis consumption for LTA and HTA groups. 
 
 
 
 
 
 
 
 
Table 2. Means, Standard deviations and statistical analysis/Bayes Factors for 
1
H-MRS quality control measures, right 
medial PFC Glu and GABA levels (Corr & /C) by LTA and HTA groups. Metabolite levels are represented in arbitrary units. 
 
 
 
 LTA (n = 19) HTA (n = 20) Analysis 
STAI trait 33.05 (5.05) 49.20 (9.33) t(37) = -6.67, p <.001 
STAI state 27.79 (5.41) 38.79 (10.76) t(37) = -4.83, p <.001 
Age (years) 22.31 (5.09) 21.80 (4.25) t(37) = .34, p =.73 
Estimated IQ 109.00 (9.91) 109.30 (10.80) t(37) = .01, p = .93 
Cannabis use 
(Moderate) 
2 0 U = 155, p = .27 
Alcohol use 
(Regular) 
3 1 U = 183, p = .78 
PFC Glu/Met   Analysis (LTA vs. HTA)  
 LTA  HTA Total  t-test result BF10 
Glu Corr 7.41 
(.58) 
7.80 
(1.10) 
7.61 
(.90) 
t(37) = -1.36, p = .183 0.64 
Glu/Cr 1.00 
(.06) 
1.05 
(.08) 
1.02 
(.08) 
t(37) = -1.99, p = .054, ηpart² = .097 1.44 
S:N Ratio 60.00 
(4.77) 
60.85 
(7.01) 
60.44 
(5.96) 
t(37) = -.44, p = .662 0.34 
Line Width in 
Hz 
3.53 
(.79) 
4.26 
(1.30) 
3.90 
(1.13) 
t(31.67) = -2.128, p = .041, ηpart² = .107 1.71 
Glu CRLB  4.05 
(.62) 
3.85 
(.67) 
3.95 
(.65) 
t(37) = .98, p = .335 0.46 
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Figure 1. Reaction time and error rate data for Stroop task. (A) Mean reaction time (RT) in milliseconds (ms) and (B) error 
rate (ER) % errors by trait anxiety group and task condition. Error bars show the standard error of the mean. 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 26 
 
Figure 2. (A) Statistical Parametric Maps in axial, coronal and sagittal sections showing the main effect of the Stroop task 
(incongruent > congruent) in cortical regions. Results displayed at p < .05 FWE peak corrected. The left side of the brain is on 
the left side of the image.  
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Figure 3. (A) Scatter plot and line of best fit showing individual contrast parameter estimates by right PFC Glu Corr levels 
(arb. unit) by trait anxiety group. (B) Positioning of the voxel for right medial PFC voxel for 
1
H-MRS acquisition. (C) Statistical 
Parametric Map showing brain activations for trait anxiety Group x PFC Glu Corr interaction during incongruent trials at P 
=.05 FWE corrected threshold. Results displayed at p > .005 uncorrected for illustrative purposes.  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 28 
SUPPLEMENTARY MATERIAL 
METHODS 
Power Calculations  
Our power calculations suggest that, with independent group sizes of n = 19 (LTA) & 20 
(HTA), we would only have sufficient power to detect a significant group difference (using 
an independent sample t-test) in DLPFC activity if the effect size was > .8 (large). Thus, our 
sample size is insufficient to detect small and medium effect sizes. However, based on the 
effect size of 0.49 reported by Bishop [5] for a significant positive correlation between STAI 
trait anxiety scores and DLPFC activity (see [5] Figure 2c), our power calculation show that 
an n = 36 has > 90% power to detect a significant positive association between STAI scores 
and DLPFC activation at p =.05 (one-tailed). As our n = 39 for this analysis, we can assume 
sufficient power.  
To our knowledge only one previous study has reported differences in prefrontal cortical Glu 
levels (in the anterior cingulate cortex) for high vs. low trait anxiety groups [29]. This study 
reports an effect size of .85, but is based on a small sample. Generically, using mean and 
standard deviation data from an independent 
1
H-MRS glutamate dataset [70] we calculated an 
effect size for PFC glutamate levels based on a small to medium (15%) change in glutamate 
levels between groups (Cohen’s d = .90). Using an intermediate effect size of .875 our power 
calculation shows that n = 19 has >85% power to detect a significant independent group 
difference for PFC glutamate levels at p = .05 (one-tailed).  
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RESULTS 
Task Performance with trait anxiety as a continuous covariate 
A repeated measures ANCOVA including STAI trait scores as a continuous covariate, 
revealed no significant effect of condition on ER (F(1, 37) = 1.08, p = .305), there was 
however a significant effect of trait anxiety on ER (F(1, 37) = 7.01, p = .012, ηpart² = .16). 
There was also a significant trait anxiety x task interaction effect (F(1, 37) = 5.68, p = .022, 
ηpart² = .13). The relative likelihood of this model compared to the null hypothesis is BF10 = 
6410.85. 
 The main effect of condition on RT was not significant (F(1, 37) = 0.12, p = .730), neither 
was there a significant effect of trait anxiety on RT (F(1, 37) < 0.01, p = .993). There was a 
trend towards a significant trait anxiety x task interaction effect (F(1, 37) = 3.16, p = .084, 
ηpart² = .08). The relative likelihood of this model compared to the null hypothesis is BF10 = 
0.55. 
1
H- MRS: Glu Corr, trait anxiety (continuous variable) and DLPFC activation 
In an additional analysis STAI trait anxiety scores were included as a continuous variable 
(covariate) in an otherwise identical analysis to what has been reported in the main results 
section. Within the DLPFC ROI there were no suprathreshold effects of trait anxiety during 
Incongruent > Congruent trials. There were furthermore no suprathreshold effects of Glu 
Corr. There was no significant interaction between Glu Corr and trait anxiety in the left 
DLPFC ROI but there was a significant interaction in the right DLPFC ROI (x, y, z = 24, 32, 
22, Z = 3.59; PFWE (Peak-level) = .045).  
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The whole brain analysis further showed a significant interaction between PFC Glu/Cr levels, 
trait anxiety and activity in the right anterior cingulate gyrus (x, y, z = 14, 24, 36, Z = 4.83; 
PFWE (Peak-level) = .034). 
Trait Anxiety Group x 
1
H-MRS interactions exploratory whole brain analysis 
The whole brain analysis revealed no regions with a significant interaction effect for PFC Glu 
Corr levels × trait anxiety group during incongruent trials.
 
1
H- MRS: Glu/Cr  
There were no significant correlations between PFC GMV and Glu levels (r = .20 p =.21, 
BF10 = 0.41), nor between WMV and Glu levels (r = -.24 p = .14, BF10 = 0.57). Thus, it is 
unlikely that individual differences in PFC GMV and WMV influence Glu levels. There were 
no significant differences between LTA and HTA groups for PFC Glu/Cr. However, there 
was a strong trend towards higher PFC Glu/Cr levels in the HTA group relative to the LTA 
group (t(37) = -1.99, p = .054, ηpart² = .097, BF10 = 1.44; Table 2).  
Trait Anxiety Group x 
1
H-MRS interactions for Glu/ Cr  
There was a trend towards an interaction between PFC Glu/Cr levels, trait anxiety group and 
activity in the right DLPFC ROI (x, y, z = 30, 28, 16, Z = 3.45; PFWE (Peak-level) = .070). There 
was a trend towards a positive association between right PFC Glu/Cr and DLPFC brain 
activity in the LTA group. The whole brain analysis further showed a significant interaction 
between PFC Glu/Cr levels, trait anxiety group and activity in the left inferior/middle frontal 
gyrus (x, y, z = -48, 26, 10, Z = 4.83; PFWE (Peak-level) = .036) (Figure s1B). The scatter plot in 
Figure s1A shows that during incongruent trials (incongruent > congruent) the LTA group 
showed a positive association between right PFC Glu/Cr and brain activity in the left 
inferior/middle frontal gyrus. In the HTA group, during incongruent trials, PFC Glu/Cr levels 
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were not associated with activation in this region. This interaction effect was not accounted 
for by task performance (ER).  
 
Figure s1. (A) Scatter plot and line of best fit showing individual contrast parameter estimates by PFC Glu/Cr levels (arb. 
unit) by trait anxiety group. Statistical Parametric Map showing brain activations for trait anxiety Group x PFC Glu/Cr 
interaction during incongruent trials. Results displayed at p>.001 uncorrected for illustrative purposes.  
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SUPPLEMENTARY TABLES 
 
 
Table s1: Frequency of alcohol and cannabis consumption across participants. 
 No or 
experimental use 
Occasional use Moderate use Regular and 
severe use 
Alcohol 4 21 12 2 
Cannabis 35 2 2 0 
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Table s2: Regions and MNI coordinates for activations during Incongruent > Congruent Stroop Trials (p FWE peak < .05). 
 
       MNI coordinates (mm) 
Cluster Hemisphere 
PFWE 
(Peak-level) 
Z x y z 
Anterior cingulate 
gyrus/superior frontal 
gyrus 
R <.001 5.87 -8 12 48 
 <.001 5.77 -6 -8 52 
 0.001 5.55 -8 -4 66 
Precentral gyrus R <.001 5.70 36 -12 56 
 0.024 4.91 32 -20 50 
Precentral gyrus L 0.001 5.55 -36 -16 56 
 0.001 5.53 -28 -18 48 
 0.006 5.23 -26 -10 52 
Anterior cingulate gyrus R 0.008 5.17 16 16 34 
 0.022 4.93 10 16 40 
Inferior Frontal Gyrus/ 
Precentral Gyrus/ Middle 
frontal Gyrus 
L 0.021 4.95 -40 10 28 
Precentral Gyrus/ Middle 
frontal Gyrus 
L 0.025 4.90 -38 0 40 
Insula L 0.026 4.90 -42 22 0 
Posterior Supramarginal 
Gyrus 
L 0.035 4.83 -54 -46 22 
Precentral Gyrus/ Middle 
frontal Gyrus 
L 0.041 4.79 -36 -2 44 
Middle Frontal Gyrus/ 
Inferior Frontal Gyrus 
L 0.042 4.78 -38 18 28 
Putamen L 0.049 4.74 -24 0 14 
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Table s3 
Table s3: Mean, standard deviations and statistics for metabolite levels for all participants, LTA and HTA groups (metabolite 
levels reported in arbitrary units). 
 
PFC Metabolite 
Levels 
Total  LTA Group  HTA Group  Analysis (LTA vs. 
HTA group) 
Creatine  6.47 (.52) 6.57 (.44) 6.37 (.59) t(37) = 1.17 p = .249 
GABA 1.78 (.28) 1.73 (.22) .1.83 (.33) t(37) = 1.06 p = .296 
GABA Corr 2.06 (.35) 1.97 (.27) 2.14 (.40) t(37) = -1.62, p = .113 
GABA/Cr .28 (.05) .26 (.03) .29 (.06) t(37) = -1.65, p = .107 
Gln .20 (.06) .19 (.05) .21 (.07) t(37) = -.93 p =.360 
Glu 6.59 (.58) 6.54 (.46) 6.64 (.68) t(37) = -.52 p =.609 
mI 5.67 (.47) 5.73 (.50) 5.62 (.44) t(37) =.699 p =.489 
NAA 8.39 (.66) 8.50 (.44) 8.29(.81) t(37) = 1.02 p = .315 
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